Klabax

Clarithromycin, the active ingredient in Klabax, is a macrolide antibiotic presented as a tablet for oral use. It treats a range of bacterial infections, including respiratory, sinus, skin and soft‑tissue infections, and is used in combination regimens for Helicobacter pylori eradication.

GNH USA supplies Klabax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches to meet global demand through reliable logistics and dedicated customer support.

Clarithromycin is indicated for several bacterial infections affecting the respiratory tract, sinuses, skin and gastrointestinal system.

- Community‑acquired pneumonia: helps clear the infection and improves breathing function. - Acute bacterial sinusitis: reduces sinus inflammation and bacterial load. - Acute bacterial bronchitis: alleviates cough and clears airway pathogens. - Skin and soft‑tissue infections: eradicates causative bacteria and promotes wound healing. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial eradication as part of a multi‑drug regimen.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often transient. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered or metallic taste. - Headache: mild to moderate intensity. - Vomiting: occasional episodes.

Serious or Rare Side Effects: - QT prolongation: potential cardiac rhythm disturbances. - Severe allergic reactions: rash, swelling, anaphylaxis. - Clostridioides difficile infection: severe colitis risk. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Arrhythmia: irregular heartbeats in susceptible patients. - Hepatotoxicity: rare liver injury.

Clarithromycin should be used with careful clinical assessment and monitoring. - Assess renal function: adjust use in patients with impaired kidney function. - Monitor liver enzymes: watch for hepatic adverse effects. - Avoid in known QT prolongation: risk of cardiac arrhythmias. - Use with caution in pregnancy (Category B): discuss benefits and risks. - Review concomitant medications: consider potential drug interactions. - Store at room temperature: keep in the original pack, protect from moisture.

Clarithromycin interacts with several drugs that may alter its safety or efficacy.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase clarithromycin levels and toxicity. - Certain statins (e.g., simvastatin, lovastatin): heightened risk of rhabdomyolysis. - QT‑prolonging agents (e.g., quinidine, amiodarone): additive cardiac risk.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce absorption, separate dosing. - Warfarin: monitor INR for potential anticoagulation changes. - Theophylline: monitor serum levels for possible increase.